22:34 on September 27, 2021, Beijing time, OTC market in the United StatesAcura Pharmaceutical (ACUR.us)The stock fluctuated, with the share price rising 16.00%. As of press time, the stock was trading at US $0.580 per share, with a turnover of 5500 shares, a turnover rate of 0.01% and an amplitude of 0.005%.
The most recent results show that the stock achieved operating income of $613000.00, net profit of-$387000.00, earnings per share of-$0.010, gross profit-- and a price-to-earnings ratio of-10.20 times.
In terms of agency rating, there is currently no agency to make "buy, hold, sell" recommendations on the stock.
In the pharmaceutical industry in which Acura Pharmaceuticals shares are located in the US OTC market, the overall decline was 0.5%. Among its related stocksClarus Therapeutics Hldgs Inc、Optinose Inc、Radius Health IncThe increase is relatively large.Flora Growth Corp.、Zynerba Pharmaceuticals Inc、Denawi PharmaceuticalsRelatively active, with turnover rates of 4.00%, 2.77% and 2.59%, respectively. The related stocks with large amplitudes are Denawi Pharmaceuticals, Flora Growth Corp.,Endo PharmaceuticalThe amplitudes were 11.14%, 10.08% and 9.85%, respectively.
American OTC Market Acura Pharmaceutical Company profile: Acura Pharmaceutical Company is a pharmaceutical company. The company uses proprietary and unbreakable technology platforms to develop and produce products against drug abuse and misuse.
(the above content is completed by Money Call, a self-selected intelligent machine writer, and is only used as a reference for users to look at the market, not as a basis for transaction. )